BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30581036)

  • 1. Genomic characterization of cervical cancer based on human papillomavirus status.
    Zhang L; Jiang Y; Lu X; Zhao H; Chen C; Wang Y; Hu W; Zhu Y; Yan H; Yan F
    Gynecol Oncol; 2019 Mar; 152(3):629-637. PubMed ID: 30581036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of HPV-independent cervical cancers.
    Banister CE; Liu C; Pirisi L; Creek KE; Buckhaults PJ
    Oncotarget; 2017 Feb; 8(8):13375-13386. PubMed ID: 28077784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK).
    Powell N; Cuschieri K; Cubie H; Hibbitts S; Rosillon D; De Souza SC; Molijn A; Quint W; Holl K; Fiander A
    J Clin Virol; 2013 Nov; 58(3):571-4. PubMed ID: 24051043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix.
    Minaguchi T; Yoshikawa H; Nakagawa S; Yasugi T; Yano T; Iwase H; Mizutani K; Shiromizu K; Ohmi K; Watanabe Y; Noda K; Nishiu M; Nakamura Y; Taketani Y
    Cancer Lett; 2004 Jul; 210(1):57-62. PubMed ID: 15172121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
    Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
    Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of HPV Integration and Genomic Patterns Delineating the Clinical Landscape of Cervical Cancer.
    Akeel RA
    Asian Pac J Cancer Prev; 2015; 16(18):8041-5. PubMed ID: 26745036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
    Baser E; Can F; Unlukaplan M; Ayhan A
    Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
    Alsbeih GA; Al-Harbi NM; Bin Judia SS; Khoja HA; Shoukri MM; Tulbah AM
    Cancer; 2017 Jul; 123(13):2459-2466. PubMed ID: 28393355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
    Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
    Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of HPV type on prognosis in patients diagnosed with invasive cervical cancer.
    Cuschieri K; Brewster DH; Graham C; Nicoll S; Williams AR; Murray GI; Millan D; Johannessen I; Hardie A; Cubie HA
    Int J Cancer; 2014 Dec; 135(11):2721-6. PubMed ID: 24740764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations.
    Kwon EJ; Ha M; Jang JY; Kim YH
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
    Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
    Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
    Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
    J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of human papillomavirus viral load in correlation with different therapeutic modalities in cervical cancer patients.
    Cao M; Shah W; Qi J; Zhou Y; Wang Y; Chen H
    Pathol Res Pract; 2016 Sep; 212(9):804-10. PubMed ID: 27461827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma.
    Ueno S; Sudo T; Oka N; Wakahashi S; Yamaguchi S; Fujiwara K; Mikami Y; Nishimura R
    Int J Gynecol Cancer; 2013 Jul; 23(6):1084-91. PubMed ID: 23792604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
    Liu Y; Lu Z; Xu R; Ke Y
    Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of tumor suppressor gene PML in uterine cervical carcinogenesis: impact of human papillomavirus infection (HPV).
    Singh N; Sobti RC; Suri V; Nijhawan R; Sharma S; Das BC; Bharadwaj M; Hussain S
    Gynecol Oncol; 2013 Mar; 128(3):420-6. PubMed ID: 23220564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas.
    Ogura K; Ishi K; Matsumoto T; Kina K; Nojima M; Suda K
    Pathol Int; 2006 Jun; 56(6):301-8. PubMed ID: 16704493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.